Researchers have linked high levels of the appetite hormone leptin with reduced incidence of Alzheimers.
The 12-year study of 200 people, published in the Journal of the American Medical Association, found those with the lowest levels of leptin were more likely to develop the disease than those with the highest. It could pave the way for further leptin studies as a means for heading off Alzheimer's. The hope is leptin could eventually be used as both a marker and a treatment. The results still need to be verified in other studies, but if confirmed, they could further determine to what degree lifestyle and other factors like habitual exercise figure in the prevention and treatment of Alzh...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
